Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID

Bibliographic Details
Published in:	Critical Care
Main Authors:	Patrick M. Honore, Sebastien Redant, Thierry Preseau, Bogdan Vasile Cismas, Keitiane Kaefer, Leonel Barreto Gutierrez, Sami Anane, Rachid Attou, Andrea Gallerani, David De Bels
Format:	Article
Language:	English
Published:	BMC 2021-12-01
Subjects:	Endocan ARDS severity Pulmonary embolism
Online Access:	https://doi.org/10.1186/s13054-021-03850-9

Similar Items

Endocan as a biomarker for acute respiratory distress syndrome: A systematic review and meta‐analysis
by: Amir Hossein Behnoush, et al.
Published: (2024-09-01)

Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
by: Patrick M. Honore, et al.
Published: (2021-12-01)

Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
by: Patrick M. Honore, et al.
Published: (2022-06-01)

Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
by: Håkon Reikvam, et al.
Published: (2022-03-01)

The Role of Endocan in Cardiometabolic Disorders
by: Aleksandra Klisic, et al.
Published: (2023-05-01)

Difference of 11 years between two periods of VV-ECMO does not impact mortality in large centres: we are not sure
by: Patrick M. Honore, et al.
Published: (2022-05-01)

Comparison of the Role of Endocan With Other Laboratory Tests in Diagnosis of Acute and Perforated Appendicitis in Children
by: Mehmet Nuri CEVİZCİ, et al.
Published: (2020-04-01)

Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension
by: Sevil Fisekci Oktar, et al.
Published: (2019-11-01)

Diagnostic Value of Ascitic Endocan in Spontaneous Bacterial Peritonitis
by: Ibrahim Abd-Elfattah, et al.
Published: (2023-09-01)

A novel inflammatory marker for extensive ulcerative colitis; Endocan
by: Bulent Albayrak, et al.
Published: (2023-04-01)

Serum Endocan Levels as A Valuable Biomarker for Discrimination of Critical and Stable COVID-19 Patients
by: Derya Öztürk, et al.
Published: (2023-06-01)

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
by: Patrick M. Honore, et al.
Published: (2020-09-01)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
by: Patrick M. Honore, et al.
Published: (2019-05-01)

Serum endocan levels in fresh IVF/ICSI cycles in women with endometriosis: a comparative prospective study
by: Mehmet Ufuk Ceran, et al.
Published: (2022-03-01)

Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
by: Carmela Morace, et al.
Published: (2023-08-01)

Elevated serum endocan levels in patients with rosacea: A new therapeutic target?
by: Sevilay Kilic, et al.
Published: (2021-01-01)

Endocan serum concentration in uninfected newborn infants
by: Gabriela I Zonda, et al.
Published: (2019-09-01)

Cardiac biomarkers in coronary slow flow: Endocan and omentin-1
by: Kaan Okyay
Published: (2019-06-01)

Endocan As A Potential Marker of Early Endothelial Dysfunction In Polycystic Ovary Syndrome (PCOS)
by: Erman Çakal, et al.
Published: (2021-03-01)

Serum endocan levels in children with febrile neutropenia
by: Eylem Kiral, et al.
Published: (2016-03-01)

PSP is a promising biomarker of sepsis; however, potential elimination by RRT must be considered
by: Patrick M. Honore, et al.
Published: (2022-11-01)

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
by: Patrick M. Honore, et al.
Published: (2022-01-01)

Validity of endocan as a biomarker in systemic sclerosis: relation to pathogenesis and disease activity
by: Marwa Yahia Mahgoub, et al.
Published: (2020-11-01)

Serum endocan levels in non-ST segment elevation myocardial infarction patients
by: Adem Melekoglu, et al.
Published: (2026-06-01)

The Role of Endocan Expression in the Diagnosis and Grading of Precancerous Gastric Lesions
by: Mehmet Kok, et al.
Published: (2025-05-01)

Serum Endoglin and Endocan Levels in Rosacea and Their Association with Cardiovascular Risk Factors: A Case-Control Study
by: Melodi Çekiç, et al.
Published: (2025-07-01)

Endocan Knockdown Down-Regulates the Expression of Angiogenesis-Associated Genes in Il-1ß Activated Chondrocytes
by: Michele Scuruchi, et al.
Published: (2023-05-01)

Serum concentration of endocan, fetuin-A, and endothelin in plaque psoriasis – coincidence or fate? A preliminary study
by: Marcelina Grochowiec, et al.
Published: (2021-05-01)

Could Serum Endocan Be a Vascular Endothelial Marker in Relapsing-Remitting Multiple Sclerosis?
by: Arife Çimen Atalar, et al.
Published: (2021-09-01)

Serum Endocan as a Diagnostic Marker of Late Onset Sepsis in Preterm Neonates (single center prospective study)
by: Mohamed Mahgoob, et al.
Published: (2021-01-01)

Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study
by: Mario Šafer, et al.
Published: (2025-05-01)

Dengue Virus Induces the Expression and Release of Endocan from Endothelial Cells by an NS1–TLR4-Dependent Mechanism
by: Carlos Alonso Domínguez-Alemán, et al.
Published: (2021-06-01)

Deleterious Effect of Maternal administration of Acrylamide on Lung Development and the Prospective Effect of Ascorbic Acid: Pertinent Role of Serum Endocan
by: Marwa Ahmad, et al.
Published: (2020-03-01)

Is There Any Relationship Between Serum Endocan Levels and Carotid Intima-media Thickness in Patients with Fibromyalgia?
by: Fatih Bağcıer, et al.
Published: (2019-08-01)

Can endocan serve as a molecular “hepatostat” in liver regeneration?
by: Sinan Efe Yazici, et al.
Published: (2023-02-01)

Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension
by: Alberto Lo Gullo, et al.
Published: (2021-05-01)

Endocan in prediabetes, diabetes, and diabetes-related complications: a systematic review and meta-analysis
by: Amirmohammad Khalaji, et al.
Published: (2023-05-01)

Endocan level and its association with glycemic and inflammatory indices in diabetic nephropathy
by: Lujain Mohammed Al-Mayahi, et al.
Published: (2026-04-01)

The Evaluation of Serum Endocan, Interleukin-6, and CRP Levels Following Sleeve Gastrectomy
by: Turkmen Sariyildiz G, et al.
Published: (2023-10-01)

Association of plasma endocan levels with metabolic parameters and predictive value of endocan for the development of complications in patients with type 2 diabetes mellitus: An observational study
by: Kenana Ljuca, et al.
Published: (2024-12-01)